High content analysis: A sensitive tool to detect and quantify the cytotoxic, synergistic and antagonistic effects of chemical contaminants in foods

Toxicology Letters

Volumn 233, Issue 3, 2015, Pages 278-286

  Clarke, R ^a   Connolly, L ^a   Frizzell, C ^a   Elliott, C T ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cytotoxicity; High content analysis; Mixture toxicity; Mycotoxins; Synergy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MYCOTOXIN; NEUTRAL RED; AFLATOXIN B1; FUMONISIN; FUMONISIN B1; OCHRATOXIN;

ANIMAL CELL; ARTICLE; CELL COUNT; CELLULAR PARAMETERS; CONTENT ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG MIXTURE; FOOD CONTAMINATION; HIGH CONTENT ANALYSIS; LAW; MASS; MEMBRANE PERMEABILITY; MITOCHONDRIAL MASS; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NONHUMAN; NUCLEAR AREA; NUCLEAR INTENSITY; PLASMA MEMBRANE PERMEABILITY; PRIORITY JOURNAL; ANIMAL; BOVINAE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DRUG EFFECTS; DRUG POTENTIATION;

AFLATOXIN B1; ANIMALS; CATTLE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELLS, CULTURED; DRUG SYNERGISM; FOOD CONTAMINATION; FUMONISINS; MEMBRANE POTENTIAL, MITOCHONDRIAL; OCHRATOXINS;

EID: 84923048094     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2015.01.011     Document Type: Article

References (42)

1. Abel S., Gelderblom W.C.A. Oxidative damage and fumonisin B1-induced toxicity in primary rat hepatocytes and rat liver in vivo. Toxicology 1998, 131:120-131.
2. Abraham V.C., Towne D.L., Waring J.F., Warrior U., Burns D.J. Application of a high content multi-parameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans. J. Biomol. Screen. 2008, 2008(13):527-537.
3. Bhat R.V., Shetty P.H., Amruth R.P., Sudershan R.V. A food borne disease outbreak due to the consumption of moldy sorghum and maize containing fumonisin mycotoxins. J. Clin. Toxicol. 1997, 35:249-255.
4. Bouslimi A., Bouaziz C., Ayed-Boussema I., Hassen W., Bacha H. Individual and combined effects of ochratoxin A and citrinin on viability and DNA fragmentation in cultured Vero cells and chromosome abberations in mice bone marrow cells. Toxicology 2008, 251:1-7.
5. Buchser W., Collins M., Garyantes T., Guha R., Haney S., et al. Assay development guidelines for image-based high content screening, high content analysis and high content imaging. Assay Guidance Manual 2004-2012, Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD. G.S. Sittampalam, N. Gal-Edd, M. Arkin, D. Auld, C. Austin (Eds.).
6. Clarke R., Connolly L., Frizzell C., Elliott C. Cytotoxic assessment of the regulated, co-existing mycotoxins aflatoxin B1, fumonisin B1 and ochratoxin, in single, binary and tertiary mixtures. Toxicon 2014, 90:70-81.
7. Creppy E.E., Röschenthaler R., Dirheimer G. Inhibition of protein synthesis in mice by ochratoxin A and its preventionby phenylalanine. Food Chem. Toxicol. 1984, 22:883-886.
8. Creppy E.E., Chiarappa P., Baudrimont I., Borracci P., Moukhaa S., et al. Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity?. Toxicology 2004, 201:115-123.
9. Golli-Bennour E.E., Kouidhi B., Bouslimi A., Abid-Essefi S., Hassen W., et al. Cytotoxicity and genotoxicity induced by aflatoxin B1, ochratoxin A, and their combination in cultured Vero cells. J. Biochem. Mol. Toxicol. 2010, 24(1):42-50.
10. Halbin K.J., Kouakou B., Dago G. Low level of ochratoxin A enhances aflatoxin B1 induced cytotoxicity and lipid peroxidation in both human intestinal (caco-2) and hepatoma (HepG2) cell lines. J. Nutr. Food Sci. 2013, 2(6):294-300.
11. Heussner A.H., Dietrich D.R., O'Brien E. In vitro investigation of individual and combined cytotoxic effects of ochratoxin A and other selected mycotoxins on renal cells. Toxicol. In Vitro 2006, 20:332-341.
12. Klariç M.S., Pepeljnjak S., Domijan A.M., Petrik J. Lipid peroxidation and glutathione Levels in porcine kidney PK15 cells after individual and combined treatment with fumonisin B1, beauvericin and ochratoxin A. Basic Clin. Pharmacol. Toxicol. 2006, 100:157-164.
13. Klarić M.S., Rumora L., Ljubanović D., Pepeljnjak S. Cytotoxicity and apoptosis induced by fumonisin B1, beauvericin and ochratoxin A in porcine kidney PK15 cells: effects of individual and combined treatment. Arch. Toxicol. 2008, 82:247-255.
14. Klarić M.S., Pepeljnjak S., Rozgaj R. Genotoxicity of fumonisin B1 beauvericin and ochratoxin A in porcine kidney PK15 cells: effects of individual and combined treatment. Croat. Chem. Acta 2008, 81:139-146.
15. Klarić M.S., Želježić D., Rumora L., Peraica M., Pepeljnjak S., et al. A potential role of calcium in apoptosis and aberrant chromatin forms in porcine kidney PK15 cells induced by individual and combined ochratoxin A and citrinin. Arch. Toxicol. 2012, 86:97-107.
16. Klarić M.S., Raši D., Peraica M. Deleterious effects of mycotoxin combinations involving ochratoxin A. Toxins 2013, 5:1965-1987.
17. Lei M., Zhang N., Desheng Q. In vitro investigation of individual and combined cytotoxic effects of aflatoxin B1 and other selected mycotoxins on the cell line porcine kidney 15. Exp. Toxicol. Pathol. 2013, 63:1149-1157.
18. McKean C., Tang L., Tang M., Billam M., Wang Z., Theodorakis C.W., Kendall R.J., Wang J.S. Comparative acute and combinative toxicity of aflatoxin B1and fumonisin B1in animals and human cells. Food Chem. Toxicol. 2006, 44:868-876.
19. Mirochnitchenko O., Weisbrot-Lefkowitz M., Reuhl K., Chen L., Yang C., Inouye M. Acetaminophen toxicity. J. Biol. Chem. 1999, 274(15):10349-10355.
20. Mobio T.A., Abado-Begonee K., Ennamany R., Fleurat-Lessart F., Shier W.T., Badria F., Creppy E.E. Lipid peroxidation as a sensitive marker of cellular response to fumonisin B1: implication in cytotoxicity and inhibition of protein DNA syntheses. Toxicol. Lett. 1996, 88:71.
21. Mobio T.A., Abado-Begonee K., Ennamany R., Fleurat-Lessart F., Shier W.T., Badria F., Creppy E.E. Implication of lipid peroxidation in cytotoxicity and genotoxicity of fumonisin B1. Toxicol. Lett. 1998, 95:154.
22. O'Brien P., Haskins J.R. In vitro cytotoxicity assessment. High Content Screening (Methods in Molecular Biology) 2007, 356:415-425. Humana Press, NJ, USA.
23. O'Brien P. High content analysis of sublethal cytotoxicity in human HepG2 hepatocytes for assessing potential and mechanism for chemical and drug induced human toxicity. High Content Screening (Science, Techniques, and Applications) (Haney, S.A) 2008, 293-315. Wiley, NJ.
24. O'Brien P.J., Canelas-Domingos M. Use of high content analysis in toxicologic clinical pathology for identification and monitoring of translational safety biomarkers. Int. Drug Discov. 2009, 1:17-21.
25. O'Brien P.J., Irwin W., Diaz D., Howard-Cofield E., Krejsa C.M., et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol. 2006, 80:580-604.
26. Omar R.F., Hasinoff B.B., Mejilla F., Rahimtula A.D. Mechanism of ochratoxin A-stimulated lipid peroxidation. Biochem. Pharmacol. 1990, 40:1183-1191.
27. Park J.W., Kim E.K., Shon D.H., Kim Y.B. Natural co-occurrence of aflatoxin B1, fumonisin B1 and ochratoxin A in barley and corn foods from Korea. Food Addit. Contam. 2002, 19(11):1073-1080.
28. Puntaric D., Bosnir J., Smit Z., Skes I., Baklaic Z. Ochratoxin A in corn and wheat: geographical association with endemic nephropathy. Croat. Med. J. 2001, 42:175-180.
29. Rahimtula A.D., Bereziat J.C., Bussachini-Griot V., Bartsch H. Lipid peroxidation as possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 1988, 37:4469-4477.
30. Raj H.G., Venkitassubramanian T.A. Mitochondrial injury and impaired liver function in aflatoxin toxicity. Eur. Food Res. Technol. 1974, 154:201-205.
31. Rawlinson L.B., O'Brien P.J., Brayden D.J. High content analysis of cytotoxic effects of pDMAEMA on human intestinal epithelial and monocyte cultures. J. Control. Release 2010, 146:84-92.
32. Repetto G., Del Peso A., Zurita J.L. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat. Protoc. 2008, 3:1125-1131.
33. Rodncks J.V., Hesseltine C.W., Mehlman M.A. Mycotoxins in Human and Animal Health 1977, Pathotox, Park Forest South, IL.
34. Ruiz M.J., Macakova P., Juan-Garcia A., Font G. Cytotoxic effects of mycotoxin combinations in mammalian kidney cells. Food Chem. Toxicol. 2011, 49:2718-2724.
35. Sangare-Tigori B., Moukha S., Kouadio H.J., Betbeder A.M., Dano D.S., et al. Co-occurrence of aflatoxin B1, fumonisin B1, ochratoxin A and zearalenone in cereals and peanuts in Cote D'Ivoire. Food Addit. Contam. 2005, 23(10):1000-1007.
36. Smith J.E., Moss M.O. Mycotoxins: Formation, Analysis and Significance 1985, Wiley, Chichester, UK.
37. Taylor D.L. Past, present, and future of high content screening and the field of cellomics. High Content Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery 2007, 3-18. Humana Press, NJ, USA. D.L. Taylor, J.R. Haskins, K.A. Guiliano (Eds.).
38. Walsh E.G., Maher S., Devocelle M., O'Brien P.J., Baird A.W., et al. High content analysis to determine cytotoxicity of the antimicrobial peptide melittin and selected structural analoques. Peptides 2011, 32:1764-1773.
39. Warth B., Parich A., Atehnkeng J., Bandyopadhyay R., Schuhmacher R., et al. Quantitation of mycotoxins in food and feeds from Burkina Faso and Mozambique using a modern LC-MS/MS multitoxin Method. J. Agric. Food Chem. 2012, 60:9352-9363.
40. Weber F., Freudinger R., Schwerdt G., Gekle M. A rapid screening method to test apoptotic synergisms of ochratoxin A with other nephrotoxic substances. Toxicol. In Vitro 2005, 19:135-143.
41. Xu J.J., Diaz D., O'Brien P.J. Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. Chem. Biol. Interact. 2004, 150:115-128.
42. Xu J.J., Henstock P.V., Dunn M.C., Smith A.R., Chabot J.R., de Graaf D. Cellular imaging predictions of clinical drug-induced liver injury. Toxicol. Sci. 2008, 105:97-105.